These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2166 related items for PubMed ID: 26034368

  • 1. Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.
    Ding SL, Yang ZW, Wang J, Zhang XL, Chen XM, Lu FM.
    World J Gastroenterol; 2015 May 28; 21(20):6317-28. PubMed ID: 26034368
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic silencing of SFRP1 and SFRP5 by hepatitis B virus X protein enhances hepatoma cell tumorigenicity through Wnt signaling pathway.
    Xie Q, Chen L, Shan X, Shan X, Tang J, Zhou F, Chen Q, Quan H, Nie D, Zhang W, Huang AL, Tang N.
    Int J Cancer; 2014 Aug 01; 135(3):635-46. PubMed ID: 24374650
    [Abstract] [Full Text] [Related]

  • 3. Alterations of RB1, p53 and Wnt pathways in hepatocellular carcinomas associated with hepatitis C, hepatitis B and alcoholic liver cirrhosis.
    Edamoto Y, Hara A, Biernat W, Terracciano L, Cathomas G, Riehle HM, Matsuda M, Fujii H, Scoazec JY, Ohgaki H.
    Int J Cancer; 2003 Sep 01; 106(3):334-41. PubMed ID: 12845670
    [Abstract] [Full Text] [Related]

  • 4. Mutations in TP53, CTNNB1 and PIK3CA genes in hepatocellular carcinoma associated with hepatitis B and hepatitis C virus infections.
    Tornesello ML, Buonaguro L, Tatangelo F, Botti G, Izzo F, Buonaguro FM.
    Genomics; 2013 Aug 01; 102(2):74-83. PubMed ID: 23583669
    [Abstract] [Full Text] [Related]

  • 5. Comprehensive analyses of mutations and hepatitis B virus integration in hepatocellular carcinoma with clinicopathological features.
    Kawai-Kitahata F, Asahina Y, Tanaka S, Kakinuma S, Murakawa M, Nitta S, Watanabe T, Otani S, Taniguchi M, Goto F, Nagata H, Kaneko S, Tasaka-Fujita M, Nishimura-Sakurai Y, Azuma S, Itsui Y, Nakagawa M, Tanabe M, Takano S, Fukasawa M, Sakamoto M, Maekawa S, Enomoto N, Watanabe M.
    J Gastroenterol; 2016 May 01; 51(5):473-86. PubMed ID: 26553052
    [Abstract] [Full Text] [Related]

  • 6. Genetic polymorphisms in the Wnt/β-catenin pathway genes as predictors of tumor development and survival in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Kim SS, Cho HJ, Lee HY, Park JH, Noh CK, Shin SJ, Lee KM, Yoo BM, Lee KJ, Cho SW, Cheong JY.
    Clin Biochem; 2016 Jul 01; 49(10-11):792-801. PubMed ID: 26968103
    [Abstract] [Full Text] [Related]

  • 7. Wnt/beta-catenin signaling pathway in hepatocellular carcinomas cases from Colombia.
    Suarez M I, Uribe D, Jaramillo CM, Osorio G, Perez JC, Lopez R, Hoyos S, Hainaut P, Pineau P, Navas MC.
    Ann Hepatol; 2015 Jul 01; 14(1):64-74. PubMed ID: 25536643
    [Abstract] [Full Text] [Related]

  • 8. Hepatitis C virus core protein epigenetically silences SFRP1 and enhances HCC aggressiveness by inducing epithelial-mesenchymal transition.
    Quan H, Zhou F, Nie D, Chen Q, Cai X, Shan X, Zhou Z, Chen K, Huang A, Li S, Tang N.
    Oncogene; 2014 May 29; 33(22):2826-35. PubMed ID: 23770846
    [Abstract] [Full Text] [Related]

  • 9. AXIN deficiency in human and mouse hepatocytes induces hepatocellular carcinoma in the absence of β-catenin activation.
    Abitbol S, Dahmani R, Coulouarn C, Ragazzon B, Mlecnik B, Senni N, Savall M, Bossard P, Sohier P, Drouet V, Tournier E, Dumont F, Sanson R, Calderaro J, Zucman-Rossi J, Vasseur-Cognet M, Just PA, Terris B, Perret C, Gilgenkrantz H.
    J Hepatol; 2018 Jun 29; 68(6):1203-1213. PubMed ID: 29525529
    [Abstract] [Full Text] [Related]

  • 10. Morphological heterogeneity in beta-catenin-mutated hepatocellular carcinomas: implications for tumor molecular classification.
    Torbenson M, McCabe CE, O'Brien DR, Yin J, Bainter T, Tran NH, Yasir S, Chen ZE, Dhanasekaran R, Ahn KS, Roberts LR, Wang C.
    Hum Pathol; 2022 Jan 29; 119():15-27. PubMed ID: 34592239
    [Abstract] [Full Text] [Related]

  • 11. Accumulation of Molecular Aberrations Distinctive to Hepatocellular Carcinoma Progression.
    Midorikawa Y, Yamamoto S, Tatsuno K, Renard-Guillet C, Tsuji S, Hayashi A, Ueda H, Fukuda S, Fujita T, Katoh H, Ishikawa S, Covington KR, Creighton CJ, Sugitani M, Wheeler DA, Shibata T, Nagae G, Takayama T, Aburatani H.
    Cancer Res; 2020 Sep 15; 80(18):3810-3819. PubMed ID: 32641413
    [Abstract] [Full Text] [Related]

  • 12. AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.
    Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishiwaki T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamaoka Y, Nakamura Y.
    Nat Genet; 2000 Mar 15; 24(3):245-50. PubMed ID: 10700176
    [Abstract] [Full Text] [Related]

  • 13. Frequent epigenetic inactivation of SFRP genes in hepatocellular carcinoma.
    Takagi H, Sasaki S, Suzuki H, Toyota M, Maruyama R, Nojima M, Yamamoto H, Omata M, Tokino T, Imai K, Shinomura Y.
    J Gastroenterol; 2008 Mar 15; 43(5):378-89. PubMed ID: 18592156
    [Abstract] [Full Text] [Related]

  • 14. SFRP1 suppressed hepatoma cells growth through Wnt canonical signaling pathway.
    Shih YL, Hsieh CB, Lai HC, Yan MD, Hsieh TY, Chao YC, Lin YW.
    Int J Cancer; 2007 Sep 01; 121(5):1028-35. PubMed ID: 17443492
    [Abstract] [Full Text] [Related]

  • 15. HBx mutations promote hepatoma cell migration through the Wnt/β-catenin signaling pathway.
    Chen Z, Tang J, Cai X, Huang Y, Gao Q, Liang L, Tian L, Yang Y, Zheng Y, Hu Y, Tang N.
    Cancer Sci; 2016 Oct 01; 107(10):1380-1389. PubMed ID: 27420729
    [Abstract] [Full Text] [Related]

  • 16. Viral-human chimeric transcript predisposes risk to liver cancer development and progression.
    Lau CC, Sun T, Ching AK, He M, Li JW, Wong AM, Co NN, Chan AW, Li PS, Lung RW, Tong JH, Lai PB, Chan HL, To KF, Chan TF, Wong N.
    Cancer Cell; 2014 Mar 17; 25(3):335-49. PubMed ID: 24582836
    [Abstract] [Full Text] [Related]

  • 17. Tankyrase inhibitors attenuate WNT/β-catenin signaling and inhibit growth of hepatocellular carcinoma cells.
    Ma L, Wang X, Jia T, Wei W, Chua MS, So S.
    Oncotarget; 2015 Sep 22; 6(28):25390-401. PubMed ID: 26246473
    [Abstract] [Full Text] [Related]

  • 18. [Hepatitis B virus X protein promotes insulin-like growth factor II gene expression by inducing hypomethylation of the P3 promoter in hepatocellular carcinoma].
    Tang S, Zhang S, Zhang X, Wu S, Li J, Jiang X, Zhou H, Luo Y, Cao M.
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr 22; 22(4):289-94. PubMed ID: 25173229
    [Abstract] [Full Text] [Related]

  • 19. Epigenetic inactivation of the canonical Wnt antagonist secreted frizzled-related protein 1 in hepatocellular carcinoma cells.
    Wu Y, Li J, Sun CY, Zhou Y, Zhao YF, Zhang SJ.
    Neoplasma; 2012 Apr 22; 59(3):326-32. PubMed ID: 22296502
    [Abstract] [Full Text] [Related]

  • 20. Hepatitis B virus X protein promotes P3 transcript expression of the insulin-like growth factor 2 gene via inducing hypomethylation of P3 promoter in hepatocellular carcinoma.
    Tang S, Hu W, Hu J, Wu S, Li J, Luo Y, Cao M, Zhou H, Jiang X.
    Liver Int; 2015 Feb 22; 35(2):608-19. PubMed ID: 24423280
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 109.